SBIR/STTR Research Award

RAPID TEST FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES

Award identifier 5b08cbfff56eae19c548ccbee371dd4d885b2595316897da0c8bc695b2e2aa9cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$104,523

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CC Technology
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (adapted from applicant's abstract): The long-term goal of this project is to develop a rapid, safe, and sensitive test for the abnormal isofomms of prion (PrP/res) proteins associated with the transmissible spongifomm encephalopathies (TSE). The Surface Enhanced Raman Immunoassay (SERIA) assay to be evaluated will facilitate testing of samples with a minimum of handling (for safety and speed) at a high level of sensitivity and specificity. This will allow development of ante mortem tests in addition to application of the assay to postmortem diagnosis of TSEs. Availably of such tests will support (a) diagnostic testing of patients potentially affected by TSEs, (b) rapid screening of animal and possibly human populations for TSEs by ante mortem (blood, Lymphoid tissues, etc.) or postmortem (Lymphoid tissues, brain) testing and, (c) studies that seek to better understand the pathogenesis of TSEs. Chronic Wasting Disease (CWD) of deer and elk will be used as a model for other TSEs. Specific goals are to evaluate sensitivity of the SERIA for CWD PrP/res in brain and blood samples and to determine specificity of the SERIA for CWD PrP/res in brain and blood samples. PROPOSED COMMERCIAL APPLICATION: Currently there are no antemortem test for TSE. This will represent the first such test and will have commercial application for testing patients suspected to have TSE. A much larger commercial application will be the screening of domestic animals to eliminate TSE.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.